Vitalhub (TSE:VHI) Given a C$13.50 Price Target at Raymond James

Vitalhub (TSE:VHI) has been assigned a C$13.50 price target by equities researchers at Raymond James in a note issued to investors on Thursday,BayStreet.CA reports. The firm currently has an “outperform” rating on the stock. Raymond James’ price objective suggests a potential upside of 43.01% from the company’s current price.

A number of other equities analysts have also recently issued reports on the company. Scotiabank set a C$14.00 target price on Vitalhub and gave the stock an “outperform” rating in a report on Thursday, January 30th. Canaccord Genuity Group raised their target price on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research report on Thursday, January 16th. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Vitalhub currently has a consensus rating of “Buy” and a consensus price target of C$11.92.

Vitalhub Stock Performance

TSE:VHI traded up C$0.28 during trading hours on Thursday, hitting C$9.44. The stock had a trading volume of 79,644 shares, compared to its average volume of 143,892. The business’s 50 day moving average is C$10.52 and its 200-day moving average is C$10.31. The company has a market cap of C$510.63 million, a price-to-earnings ratio of 153.54, a P/E/G ratio of 1.18 and a beta of 1.26. Vitalhub has a one year low of C$5.80 and a one year high of C$12.09.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.